The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation
- PMID: 11896606
- DOI: 10.1038/sj.onc.1205238
The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation
Abstract
Apoptosis is closely linked to proliferation. In this study we showed that inducing apoptosis in mouse mesangial cells with ultraviolet (UV) irradiation was associated with increased cyclin A-cyclin dependent kinase (CDK) 2 activity. Inhibiting CDK2 activity with Roscovitine or dominant negative mutant reduced apoptosis. Because apoptosis typically begins in the cytoplasm, we tested the hypothesis that the subcellular localization of CDK2 determines the proliferative or apoptotic fate of the cell. Our results showed that cyclin A-CDK2 was nuclear in proliferating cells. However, inducing apoptosis in proliferating cells with UV irradiation was associated with a decrease in nuclear cyclin A and CDK2 protein levels. This coincided with an increase in protein and kinase activity for cyclin A-CDK2 in the cytoplasm. Translocation of cyclin A-CDK2 also occurred in p53-/- mesangial cells. Finally, we showed that caspase-3 activity was significantly reduced by inhibiting CDK2 activity with Roscovitine. In summary, our results show that apoptosis is associated with an increase in cytoplasmic cyclin A-CDK2 activity, which is p53 independent and upstream of caspase-3. We propose that the subcellular localization of CDK2 determines the proliferative or apoptotic fate of the cell.
Similar articles
-
Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.Cell Growth Differ. 1999 Nov;10(11):739-48. Cell Growth Differ. 1999. PMID: 10593650
-
Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.Oncogene. 1998 May;16(20):2575-83. doi: 10.1038/sj.onc.1201791. Oncogene. 1998. PMID: 9632134
-
Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.Exp Cell Res. 2000 Aug 25;259(1):35-53. doi: 10.1006/excr.2000.4966. Exp Cell Res. 2000. PMID: 10942577
-
Two for two: Cdk2 and its role in centrosome doubling.Oncogene. 2002 Sep 9;21(40):6154-60. doi: 10.1038/sj.onc.1205826. Oncogene. 2002. PMID: 12214244 Review. No abstract available.
-
Cdk2 dethroned as master of S phase entry.Cancer Cell. 2003 Apr;3(4):305-7. doi: 10.1016/s1535-6108(03)00084-9. Cancer Cell. 2003. PMID: 12726855 Review.
Cited by
-
Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.Cancer Genomics Proteomics. 2022 May-Jun;19(3):362-371. doi: 10.21873/cgp.20326. Cancer Genomics Proteomics. 2022. PMID: 35430569 Free PMC article.
-
Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.Am J Physiol Renal Physiol. 2012 May 1;302(9):F1161-71. doi: 10.1152/ajprenal.00614.2011. Epub 2012 Jan 18. Am J Physiol Renal Physiol. 2012. PMID: 22262481 Free PMC article.
-
Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation.Int J Biol Sci. 2013 Jun 9;9(6):541-9. doi: 10.7150/ijbs.5763. Print 2013. Int J Biol Sci. 2013. PMID: 23781148 Free PMC article.
-
CDK2 and PKA mediated-sequential phosphorylation is critical for p19INK4d function in the DNA damage response.PLoS One. 2012;7(4):e35638. doi: 10.1371/journal.pone.0035638. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558186 Free PMC article.
-
Cytoplasmic initiation of cisplatin cytotoxicity.Am J Physiol Renal Physiol. 2008 Jul;295(1):F44-52. doi: 10.1152/ajprenal.00593.2007. Epub 2008 Apr 9. Am J Physiol Renal Physiol. 2008. PMID: 18400869 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous